# The Efficacy and Safety of Thymosin-α1 in Patients With HBV-related ACLF

> **NCT03082885** · NA · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 120 (actual)

## Conditions studied

- Liver Failure

## Interventions

- **DRUG:** Thymosin-α1

## Key facts

- **NCT ID:** NCT03082885
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-10
- **Primary completion:** 2019-06-02
- **Final completion:** 2019-07-30
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2021-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03082885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03082885, "The Efficacy and Safety of Thymosin-α1 in Patients With HBV-related ACLF". Retrieved via MORVS 2026-10-08 from https://api.morvs.ai/clinical/NCT03082885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*